Defining Weight-Loss-Independent Hepatic Effects of Incretin-Based Therapies.

Zhang M, Liu H, Hao Y, Chen L

Open source

DOI
10.1111/dom.71391
Published
2026 Sep 24
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71391,
  title = {Defining Weight-Loss-Independent Hepatic Effects of Incretin-Based Therapies.},
  author = {Zhang M and Liu H and Hao Y and Chen L},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.71391},
  url = {https://doi.org/10.1111/dom.71391}
}

RIS

TY  - JOUR
TI  - Defining Weight-Loss-Independent Hepatic Effects of Incretin-Based Therapies.
AU  - Zhang M
AU  - Liu H
AU  - Hao Y
AU  - Chen L
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.71391
UR  - https://doi.org/10.1111/dom.71391
ER  - 

APA

M, Z., H, L., Y, H., & L, C. (2026). Defining Weight-Loss-Independent Hepatic Effects of Incretin-Based Therapies.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71391

Source records